NICHOLAS RAINS: Open Payments
NPI 1124418363 · WEST DES MOINES, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,163 in 101 payments from 22 companies in 2025. Trend: 2023 $0 · 2024 $798 · 2025 $2,163
Food & beverage: $2,082Education: $81
| Company | Payments | Amount |
|---|---|---|
| Grifols USA, LLC | 9 | $307 |
| AstraZeneca Pharmaceuticals LP | 14 | $304 |
| Takeda Pharmaceuticals U.S.A., Inc. | 14 | $274 |
| GENZYME CORPORATION | 15 | $183 |
| PFIZER INC. | 7 | $169 |
| CSL Behring | 7 | $158 |
| Pharming Healthcare, Inc. | 5 | $95 |
| BioCryst US Sales Co., LLC | 4 | $92 |
| LEO Pharma Inc. | 3 | $75 |
| Novartis Pharmaceuticals Corporation | 4 | $74 |
Products named: DUPIXENT, Xembify, OCTAGAM IMMUNE GLOBULIN (HUMAN), EOHILIA, Hizentra, CUVITRU, TEZSPIRE, RUCONEST.
Industry payments across IA — which companies pay providers there.
